Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00685009 · ClinicalTrials.gov registry record

The Women's Health Initiative Memory Study (The WHIMS Study)

A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Completed
Registry status
7,525
Enrollment target

NCT00685009 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 7,525 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00685009 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

COMPLETED
Registry status
7,525 participants
Enrollment target

Study Summary

Excessive memory decline or dementia affects an increasing number of women as they become older. The frequency of dementia doubles every 5 years beginning at age 60, making the discovery of ways to prevent or slow the disease imperative. Previous studies have indicated that changes in memory may be associated with the female hormonal decline that occurs after menopause, but more research is needed to establish the link between menopause and poorer memory function. It is believed that taking the female hormones estrogen and/or progesterone may help improve women's health by protecting against memory decline. This study will evaluate the effects of female hormone replacement therapy (HRT) on the development and progression of memory loss in older women enrolled in the Women's Health Initiative (WHI) study.

Interventions

  • DRUG Placebo
  • DRUG Estrogen hormone therapy
  • DRUG Estrogen plus progesterone hormone therapy

Trial Details

FieldValue
Enrollment Target 7,525 participants
Start Date 1996-01
Est. Completion 2008-03

What the Registry Record Tells You About NCT00685009

The ClinicalTrials.gov registry entry for NCT00685009 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,525 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT00685009 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00685009 about?

NCT00685009 is a clinical study titled "The Women's Health Initiative Memory Study (The WHIMS Study)". Excessive memory decline or dementia affects an increasing number of women as they become older. The frequency of dementia doubles every 5 years beginning at age 60, making the discovery of ways to prevent or slow the disease imperative. Previous studies have indicated that changes in memory may be ...

What is the current status of trial NCT00685009?

This trial is currently completed. The enrollment target is 7,525 participants. The study started on 1996-01. Estimated completion is 2008-03.

What interventions are being tested in trial NCT00685009?

The interventions under investigation include: Placebo (DRUG), Estrogen hormone therapy (DRUG), Estrogen plus progesterone hormone therapy (DRUG).

Who is sponsoring clinical trial NCT00685009?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.